Breaking: FDA taps Pazdur as new top drug regulator

The longtime FDA staffer founded the agency's cancer therapy division.

Log In    Subscribe BREAKING NEWS   FDA taps Pazdur as new top drug regulator By Lizzy Lawrence Marie Miller for STAT The FDA named Richard Pazdur, its longtime overseer of cancer therapies, as top drug regulator on Tuesday.   Pazdur replaces former Center for Drug Evaluation and Research Director George Tidmarsh, who exited the agency earlier this month amid accusations of using his regulatory authority to advance a personal vendetta against a former business associate, and amid infighting with vaccine and biologics center director Vinay Prasad.  READ MORE Sign up for Daily Recap All the health and medical news you need today, in one email. Learn more. In Case You Missed It 1   At 'hush-hush' MAHA summit, RFK Jr. and deputies to mix with biotech leaders By Daniel Payne and Allison DeAngelis 2   Experts worry FDA's credibility is being shredded by scandal and 'soap opera' By Matthew Herper and Lizzy Lawrence 3   Under Vinay Prasad, employees at a key FDA center fear speaking out, look for the exits By Lizzy Lawrence 4   Is the White House's deal with pharma on GLP-1 drugs a game changer? By Elaine Chen Don't miss out on another STAT investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us